Tu1059 A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of TAK-438 (20 mg Once-Daily) Compared to Lansoprazole (30 mg Once-Daily) in Patients With Erosive Esophagitis
Iwakiri, Katsuhiko, Umegaki, Eiji, Hiramatsu, Naoki, Sakurai, Yuuichi, Hori, Tetsuharu, Kudou, Kentarou, Nishimura, Akira, Ashida, KiyoshiVolume:
146
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(14)62682-2
Date:
May, 2014
File:
PDF, 51 KB
english, 2014